Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 300 |
|
|||||
| News | - | ||||||
| Day High | 5.25 | Low High |
|||||
| Day Low | 5.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sigyn Therapeutics Inc (QB) | SIGY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.25 | 16:19:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.25 | 5.25 | 5.25 | 5.25 | 5.25 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2 | 300 | $ 5.25 | $ 1,575 | - | 0.052 - 6.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:41:58 | 245 | $ 5.25 | USD |
Sigyn Therapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 232.18M | 44.22M | 8.63M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sigyn Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SIGY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.25 | 6.34 | 5.25 | 5.74 | 273 | -1.00 | -16.00% |
| 1 Month | 6.25 | 6.34 | 5.25 | 5.74 | 254 | -1.00 | -16.00% |
| 3 Months | 5.00 | 6.34 | 4.50 | 5.39 | 322 | 0.25 | 5.00% |
| 6 Months | 0.161 | 6.34 | 0.09 | 0.2383152 | 6,519 | 5.09 | 3,160.87% |
| 1 Year | 0.11514 | 6.34 | 0.052 | 0.1773929 | 9,909 | 5.13 | 4,459.67% |
| 3 Years | 1.52 | 6.34 | 0.052 | 0.3320969 | 7,889 | 3.73 | 245.39% |
| 5 Years | 1.8501 | 6.34 | 0.052 | 0.5311334 | 6,278 | 3.40 | 183.77% |
Sigyn Therapeutics (QB) Description
| Sigyn Therapeutics is a development-stage company focused on creating therapeutic solutions to address unmet needs in global health. Sigyn Therapy, the Companys lead product candidate, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. Candidate treatment indications for Sigyn Therapy include chronic inflammation and endotoxemia in end-stage renal disease patients, sepsis (leading cause of hospital deaths), community acquired pneumonia (a leading cause of death among infectious diseases), and emerging pandemic threats. The Company's development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the delivery of FDA approved chemotherapeutic agents and ChemoPure to reduce chemotherapy toxicity. |
